(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of Each Class | Trading Symbol | Name of Each Exchange on Which Registered | ||||||
Emerging Growth Company |
Exhibit No. | Description | |||||||
99.1 | ||||||||
104 | Cover Page Interactive Data File (formatted as inline XBRL) |
Applied Materials, Inc. (Registrant) | ||||||||||||||
Date: | August 18, 2022 | By: | /s/ Teri A. Little | |||||||||||
Teri A. Little | ||||||||||||||
Senior Vice President, Chief Legal Officer and Corporate Secretary |
Q3 FY2022 | Q3 FY2021 | Change | |||||||||||||||
(In millions, except per share amounts and percentages) | |||||||||||||||||
Net sales | $ | 6,520 | $ | 6,196 | 5% | ||||||||||||
Gross margin | 46.1 | % | 47.9 | % | (1.8) points | ||||||||||||
Operating margin | 29.5 | % | 32.5 | % | (3.0) points | ||||||||||||
Net income | $ | 1,606 | $ | 1,716 | (6)% | ||||||||||||
Diluted earnings per share | $ | 1.85 | $ | 1.87 | (1)% | ||||||||||||
Non-GAAP Adjusted Results | |||||||||||||||||
Non-GAAP adjusted gross margin | 46.2 | % | 48.0 | % | (1.8) points | ||||||||||||
Non-GAAP adjusted operating margin | 30.0 | % | 32.7 | % | (2.7) points | ||||||||||||
Non-GAAP adjusted net income | $ | 1,683 | $ | 1,740 | (3)% | ||||||||||||
Non-GAAP adjusted diluted EPS | $ | 1.94 | $ | 1.90 | 2% |
Semiconductor Systems | Q3 FY2022 | Q3 FY2021 | |||||||||
(In millions, except percentages) | |||||||||||
Net sales | $ | 4,734 | $ | 4,454 | |||||||
Foundry, logic and other | 66 | % | 63 | % | |||||||
DRAM | 15 | % | 20 | % | |||||||
Flash memory | 19 | % | 17 | % | |||||||
Operating income | $ | 1,701 | $ | 1,785 | |||||||
Operating margin | 35.9 | % | 40.1 | % | |||||||
Non-GAAP Adjusted Results | |||||||||||
Non-GAAP adjusted operating income | $ | 1,708 | $ | 1,794 | |||||||
Non-GAAP adjusted operating margin | 36.1 | % | 40.3 | % |
Applied Global Services | Q3 FY2022 | Q3 FY2021 | |||||||||
(In millions, except percentages) | |||||||||||
Net sales | $ | 1,420 | $ | 1,286 | |||||||
Operating income | $ | 434 | $ | 393 | |||||||
Operating margin | 30.6 | % | 30.6 | % | |||||||
Non-GAAP Adjusted Results | |||||||||||
Non-GAAP adjusted operating income | $ | 434 | $ | 393 | |||||||
Non-GAAP adjusted operating margin | 30.6 | % | 30.6 | % |
Display and Adjacent Markets | Q3 FY2022 | Q3 FY2021 | |||||||||
(In millions, except percentages) | |||||||||||
Net sales | $ | 333 | $ | 431 | |||||||
Operating income | $ | 69 | $ | 99 | |||||||
Operating margin | 20.7 | % | 23.0 | % | |||||||
Non-GAAP Adjusted Results | |||||||||||
Non-GAAP adjusted operating income | $ | 70 | $ | 100 | |||||||
Non-GAAP adjusted operating margin | 21.0 | % | 23.2 | % |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
(In millions, except per share amounts) | July 31, 2022 | August 1, 2021 | July 31, 2022 | August 1, 2021 | |||||||||||||||||||
Net sales | $ | 6,520 | $ | 6,196 | $ | 19,036 | $ | 16,940 | |||||||||||||||
Cost of products sold | 3,514 | 3,229 | 10,144 | 8,971 | |||||||||||||||||||
Gross profit | 3,006 | 2,967 | 8,892 | 7,969 | |||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Research, development and engineering | 705 | 640 | 2,045 | 1,863 | |||||||||||||||||||
Marketing and selling | 180 | 159 | 520 | 454 | |||||||||||||||||||
General and administrative | 197 | 155 | 537 | 465 | |||||||||||||||||||
Severance and related charges | — | — | (4) | 158 | |||||||||||||||||||
Deal termination fee | — | — | — | 154 | |||||||||||||||||||
Total operating expenses | 1,082 | 954 | 3,098 | 3,094 | |||||||||||||||||||
Income from operations | 1,924 | 2,013 | 5,794 | 4,875 | |||||||||||||||||||
Interest expense | 56 | 57 | 171 | 179 | |||||||||||||||||||
Interest and other income (loss), net | (7) | 24 | 27 | 69 | |||||||||||||||||||
Income before income taxes | 1,861 | 1,980 | 5,650 | 4,765 | |||||||||||||||||||
Provision for income taxes | 255 | 264 | 716 | 589 | |||||||||||||||||||
Net income | $ | 1,606 | $ | 1,716 | $ | 4,934 | $ | 4,176 | |||||||||||||||
Earnings per share: | |||||||||||||||||||||||
Basic | $ | 1.86 | $ | 1.89 | $ | 5.63 | $ | 4.57 | |||||||||||||||
Diluted | $ | 1.85 | $ | 1.87 | $ | 5.59 | $ | 4.52 | |||||||||||||||
Weighted average number of shares: | |||||||||||||||||||||||
Basic | 864 | 908 | 877 | 914 | |||||||||||||||||||
Diluted | 869 | 918 | 883 | 923 |
(In millions) | July 31, 2022 | October 31, 2021 | |||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 2,956 | $ | 4,995 | |||||||
Short-term investments | 592 | 464 | |||||||||
Accounts receivable, net | 4,956 | 4,953 | |||||||||
Inventories | 5,506 | 4,309 | |||||||||
Other current assets | 1,424 | 1,386 | |||||||||
Total current assets | 15,434 | 16,107 | |||||||||
Long-term investments | 2,047 | 2,055 | |||||||||
Property, plant and equipment, net | 2,194 | 1,934 | |||||||||
Goodwill | 3,713 | 3,479 | |||||||||
Purchased technology and other intangible assets, net | 337 | 104 | |||||||||
Deferred income taxes and other assets | 2,436 | 2,146 | |||||||||
Total assets | $ | 26,161 | $ | 25,825 | |||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
Current liabilities: | |||||||||||
Accounts payable and accrued expenses | $ | 4,005 | $ | 4,268 | |||||||
Contract liabilities | 2,828 | 2,076 | |||||||||
Total current liabilities | 6,833 | 6,344 | |||||||||
Long-term debt | 5,456 | 5,452 | |||||||||
Income taxes payable | 955 | 1,090 | |||||||||
Other liabilities | 847 | 692 | |||||||||
Total liabilities | 14,091 | 13,578 | |||||||||
Total stockholders’ equity | 12,070 | 12,247 | |||||||||
Total liabilities and stockholders’ equity | $ | 26,161 | $ | 25,825 |
(In millions) | Three Months Ended | Nine Months Ended | |||||||||||||||||||||
July 31, 2022 | August 1, 2021 | July 31, 2022 | August 1, 2021 | ||||||||||||||||||||
Cash flows from operating activities: | |||||||||||||||||||||||
Net income | $ | 1,606 | $ | 1,716 | $ | 4,934 | $ | 4,176 | |||||||||||||||
Adjustments required to reconcile net income to cash provided by operating activities: | |||||||||||||||||||||||
Depreciation and amortization | 108 | 98 | 321 | 289 | |||||||||||||||||||
Severance and related charges | — | — | (4) | 149 | |||||||||||||||||||
Share-based compensation | 95 | 81 | 314 | 272 | |||||||||||||||||||
Deferred income taxes | 47 | 20 | (209) | 44 | |||||||||||||||||||
Other | 22 | (15) | 14 | (30) | |||||||||||||||||||
Net change in operating assets and liabilities | (409) | (214) | (828) | (606) | |||||||||||||||||||
Cash provided by operating activities | 1,469 | 1,686 | 4,542 | 4,294 | |||||||||||||||||||
Cash flows from investing activities: | |||||||||||||||||||||||
Capital expenditures | (210) | (137) | (564) | (462) | |||||||||||||||||||
Cash paid for acquisitions, net of cash acquired | (441) | — | (441) | (12) | |||||||||||||||||||
Proceeds from sales and maturities of investments | 374 | 400 | 1,013 | 1,024 | |||||||||||||||||||
Purchases of investments | (339) | (457) | (1,175) | (1,179) | |||||||||||||||||||
Cash used in investing activities | (616) | (194) | (1,167) | (629) | |||||||||||||||||||
Cash flows from financing activities: | |||||||||||||||||||||||
Proceeds from common stock issuances | — | — | 96 | 86 | |||||||||||||||||||
Common stock repurchases | (1,000) | (1,500) | (4,603) | (2,250) | |||||||||||||||||||
Tax withholding payments for vested equity awards | (3) | (12) | (259) | (171) | |||||||||||||||||||
Payments of dividends to stockholders | (225) | (219) | (650) | (622) | |||||||||||||||||||
Cash used in financing activities | (1,228) | (1,731) | (5,416) | (2,957) | |||||||||||||||||||
Increase (decrease) in cash, cash equivalents and restricted cash equivalents | (375) | (239) | (2,041) | 708 | |||||||||||||||||||
Cash, cash equivalents and restricted cash equivalents—beginning of period | 3,435 | 6,413 | 5,101 | 5,466 | |||||||||||||||||||
Cash, cash equivalents and restricted cash equivalents — end of period | $ | 3,060 | $ | 6,174 | $ | 3,060 | $ | 6,174 | |||||||||||||||
Reconciliation of cash, cash equivalents, and restricted cash equivalents | |||||||||||||||||||||||
Cash and cash equivalents | $ | 2,956 | $ | 6,066 | $ | 2,956 | $ | 6,066 | |||||||||||||||
Restricted cash equivalents included in deferred income taxes and other assets | 104 | 108 | 104 | 108 | |||||||||||||||||||
Total cash, cash equivalents, and restricted cash equivalents | $ | 3,060 | $ | 6,174 | $ | 3,060 | $ | 6,174 | |||||||||||||||
Supplemental cash flow information: | |||||||||||||||||||||||
Cash payments for income taxes | $ | 592 | $ | 232 | $ | 1,623 | $ | 641 | |||||||||||||||
Cash refunds from income taxes | $ | 5 | $ | 3 | $ | 133 | $ | 26 | |||||||||||||||
Cash payments for interest | $ | 35 | $ | 34 | $ | 137 | $ | 137 |
(In millions) | Q3 FY2022 | Q3 FY2021 | |||||||||
Unallocated net sales | $ | 33 | $ | 25 | |||||||
Unallocated cost of products sold and expenses | (218) | (208) | |||||||||
Share-based compensation | (95) | (81) | |||||||||
Total | $ | (280) | $ | (264) |
Q3 FY2022 | Q3 FY2021 | ||||||||||
Net Sales by Geography (In millions) | |||||||||||
United States | $ | 725 | $ | 533 | |||||||
% of Total | 11 | % | 9 | % | |||||||
Europe | $ | 529 | $ | 238 | |||||||
% of Total | 8 | % | 4 | % | |||||||
Japan | $ | 438 | $ | 449 | |||||||
% of Total | 7 | % | 7 | % | |||||||
Korea | $ | 1,224 | $ | 1,291 | |||||||
% of Total | 19 | % | 21 | % | |||||||
Taiwan | $ | 1,537 | $ | 1,261 | |||||||
% of Total | 24 | % | 20 | % | |||||||
Southeast Asia | $ | 270 | $ | 173 | |||||||
% of Total | 4 | % | 3 | % | |||||||
China | $ | 1,797 | $ | 2,251 | |||||||
% of Total | 27 | % | 36 | % | |||||||
Employees (In thousands) | |||||||||||
Regular Full Time | 31.9 | 26.0 |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
(In millions, except percentages) | July 31, 2022 | August 1, 2021 | July 31, 2022 | August 1, 2021 | |||||||||||||||||||
Non-GAAP Adjusted Gross Profit | |||||||||||||||||||||||
Reported gross profit - GAAP basis | $ | 3,006 | $ | 2,967 | $ | 8,892 | $ | 7,969 | |||||||||||||||
Certain items associated with acquisitions1 | 7 | 6 | 20 | 21 | |||||||||||||||||||
Certain incremental expenses related to COVID-192 | — | — | — | 12 | |||||||||||||||||||
Other charges | — | — | — | 2 | |||||||||||||||||||
Non-GAAP adjusted gross profit | $ | 3,013 | $ | 2,973 | $ | 8,912 | $ | 8,004 | |||||||||||||||
Non-GAAP adjusted gross margin | 46.2 | % | 48.0 | % | 46.8 | % | 47.2 | % | |||||||||||||||
Non-GAAP Adjusted Operating Income | |||||||||||||||||||||||
Reported operating income - GAAP basis | $ | 1,924 | $ | 2,013 | $ | 5,794 | $ | 4,875 | |||||||||||||||
Certain items associated with acquisitions1 | 10 | 11 | 29 | 36 | |||||||||||||||||||
Acquisition integration and deal costs | 19 | 5 | 32 | 40 | |||||||||||||||||||
Certain incremental expenses related to COVID-192 | — | — | — | 24 | |||||||||||||||||||
Severance and related charges3 | — | — | (4) | 158 | |||||||||||||||||||
Deal termination fee | — | — | — | 154 | |||||||||||||||||||
Other charges | — | — | — | 6 | |||||||||||||||||||
Non-GAAP adjusted operating income | $ | 1,953 | $ | 2,029 | $ | 5,851 | $ | 5,293 | |||||||||||||||
Non-GAAP adjusted operating margin | 30.0 | % | 32.7 | % | 30.7 | % | 31.2 | % | |||||||||||||||
Non-GAAP Adjusted Net Income | |||||||||||||||||||||||
Reported net income - GAAP basis | $ | 1,606 | $ | 1,716 | $ | 4,934 | $ | 4,176 | |||||||||||||||
Certain items associated with acquisitions1 | 10 | 11 | 29 | 36 | |||||||||||||||||||
Acquisition integration and deal costs | 12 | 5 | 28 | 41 | |||||||||||||||||||
Certain incremental expenses related to COVID-192 | — | — | — | 24 | |||||||||||||||||||
Severance and related charges3 | — | — | (4) | 158 | |||||||||||||||||||
Deal termination fee | — | — | — | 154 | |||||||||||||||||||
Realized loss (gain) on strategic investments, net | (1) | (6) | (1) | (2) | |||||||||||||||||||
Unrealized loss (gain) on strategic investments, net | 18 | (13) | (15) | (45) | |||||||||||||||||||
Other charges | — | — | — | 6 | |||||||||||||||||||
Income tax effect of share-based compensation4 | 22 | 11 | (22) | (12) | |||||||||||||||||||
Income tax effects related to intra-entity intangible asset transfers | 21 | 23 | 120 | 60 | |||||||||||||||||||
Resolution of prior years’ income tax filings and other tax items | 1 | (9) | (54) | (22) | |||||||||||||||||||
Income tax effect of non-GAAP adjustments5 | (6) | 2 | — | (43) | |||||||||||||||||||
Non-GAAP adjusted net income | $ | 1,683 | $ | 1,740 | $ | 5,015 | $ | 4,531 |
1 | These items are incremental charges attributable to completed acquisitions, consisting of amortization of purchased intangible assets. | ||||
2 | Temporary incremental employee compensation during the COVID-19 pandemic. | ||||
3 | The severance and related charges primarily related to a one-time voluntary retirement program offered to certain eligible employees. | ||||
4 | GAAP basis tax benefit related to share-based compensation is recognized ratably over the fiscal year on a non-GAAP basis. | ||||
5 | Adjustment to provision for income taxes related to non-GAAP adjustments reflected in income before income taxes. | ||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
(In millions, except per share amounts) | July 31, 2022 | August 1, 2021 | July 31, 2022 | August 1, 2021 | |||||||||||||||||||
Non-GAAP Adjusted Earnings Per Diluted Share | |||||||||||||||||||||||
Reported earnings per diluted share - GAAP basis | $ | 1.85 | $ | 1.87 | $ | 5.59 | $ | 4.52 | |||||||||||||||
Certain items associated with acquisitions | 0.01 | 0.01 | 0.03 | 0.03 | |||||||||||||||||||
Acquisition integration and deal costs | 0.01 | 0.01 | 0.03 | 0.04 | |||||||||||||||||||
Certain incremental expenses related to COVID-19 | — | — | — | 0.02 | |||||||||||||||||||
Severance and related charges | — | — | — | 0.13 | |||||||||||||||||||
Deal termination fee | — | — | — | 0.17 | |||||||||||||||||||
Realized loss (gain) on strategic investments, net | — | (0.01) | — | 0.01 | |||||||||||||||||||
Unrealized loss (gain) on strategic investments, net | 0.02 | (0.01) | (0.02) | (0.05) | |||||||||||||||||||
Other charges | — | — | — | 0.01 | |||||||||||||||||||
Income tax effect of share-based compensation | 0.03 | 0.01 | (0.03) | (0.01) | |||||||||||||||||||
Income tax effects related to intra-entity intangible asset transfers | 0.02 | 0.03 | 0.14 | 0.06 | |||||||||||||||||||
Resolution of prior years’ income tax filings and other tax items | — | (0.01) | (0.06) | (0.02) | |||||||||||||||||||
Non-GAAP adjusted earnings per diluted share | $ | 1.94 | $ | 1.90 | $ | 5.68 | $ | 4.91 | |||||||||||||||
Weighted average number of diluted shares | 869 | 918 | 883 | 923 |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
(In millions, except percentages) | July 31, 2022 | August 1, 2021 | July 31, 2022 | August 1, 2021 | |||||||||||||||||||
Semiconductor Systems Non-GAAP Adjusted Operating Income | |||||||||||||||||||||||
Reported operating income - GAAP basis | $ | 1,701 | $ | 1,785 | $ | 5,120 | $ | 4,588 | |||||||||||||||
Certain items associated with acquisitions1 | 7 | 9 | 22 | 29 | |||||||||||||||||||
Acquisition integration costs | — | — | — | (2) | |||||||||||||||||||
Certain incremental expenses related to COVID-192 | — | — | — | 12 | |||||||||||||||||||
Other charges | — | — | — | 3 | |||||||||||||||||||
Non-GAAP adjusted operating income | $ | 1,708 | $ | 1,794 | $ | 5,142 | $ | 4,630 | |||||||||||||||
Non-GAAP adjusted operating margin | 36.1 | % | 40.3 | % | 37.4 | % | 38.7 | % | |||||||||||||||
AGS Non-GAAP Adjusted Operating Income | |||||||||||||||||||||||
Reported operating income - GAAP basis | $ | 434 | $ | 393 | $ | 1,259 | $ | 1,083 | |||||||||||||||
Certain incremental expenses related to COVID-192 | — | — | — | 8 | |||||||||||||||||||
Other charges | — | — | — | 1 | |||||||||||||||||||
Non-GAAP adjusted operating income | $ | 434 | $ | 393 | $ | 1,259 | $ | 1,092 | |||||||||||||||
Non-GAAP adjusted operating margin | 30.6 | % | 30.6 | % | 30.5 | % | 30.0 | % | |||||||||||||||
Display and Adjacent Markets Non-GAAP Adjusted Operating Income | |||||||||||||||||||||||
Reported operating income - GAAP basis | $ | 69 | $ | 99 | $ | 226 | $ | 229 | |||||||||||||||
Certain items associated with acquisitions1 | 1 | 1 | 3 | 3 | |||||||||||||||||||
Certain incremental expenses related to COVID-192 | — | — | — | 1 | |||||||||||||||||||
Severance and related charges3 | — | — | — | 8 | |||||||||||||||||||
Non-GAAP adjusted operating income | $ | 70 | $ | 100 | $ | 229 | $ | 241 | |||||||||||||||
Non-GAAP adjusted operating margin | 21.0 | % | 23.2 | % | 21.2 | % | 19.8 | % | |||||||||||||||
1 | These items are incremental charges attributable to completed acquisitions, consisting of amortization of purchased intangible assets. | ||||
2 | Temporary incremental employee compensation during the COVID-19 pandemic. | ||||
3 | The severance and related charges related to workforce reduction actions globally across the Display and Adjacent Markets business. | ||||
Three Months Ended | |||||
(In millions, except percentages) | July 31, 2022 | ||||
Provision for income taxes - GAAP basis (a) | $ | 255 | |||
Income tax effect of share-based compensation | (22) | ||||
Income tax effects related to intra-entity intangible asset transfers | (21) | ||||
Resolutions of prior years’ income tax filings and other tax items | (1) | ||||
Income tax effect of non-GAAP adjustments | 6 | ||||
Non-GAAP adjusted provision for income taxes (b) | $ | 217 | |||
Income before income taxes - GAAP basis (c) | $ | 1,861 | |||
Certain items associated with acquisitions | 10 | ||||
Acquisition integration and deal costs | 12 | ||||
Realized loss (gain) on strategic investments, net | (1) | ||||
Unrealized loss (gain) on strategic investments, net | 18 | ||||
Non-GAAP adjusted income before income taxes (d) | $ | 1,900 | |||
Effective income tax rate - GAAP basis (a/c) | 13.7 | % | |||
Non-GAAP adjusted effective income tax rate (b/d) | 11.4 | % |